CZ286482B6 - Medicament for treating casual infections in mammals including human beings - Google Patents

Medicament for treating casual infections in mammals including human beings Download PDF

Info

Publication number
CZ286482B6
CZ286482B6 CZ1997209A CZ20997A CZ286482B6 CZ 286482 B6 CZ286482 B6 CZ 286482B6 CZ 1997209 A CZ1997209 A CZ 1997209A CZ 20997 A CZ20997 A CZ 20997A CZ 286482 B6 CZ286482 B6 CZ 286482B6
Authority
CZ
Czechia
Prior art keywords
medicament
infections
formula
compound
treatment
Prior art date
Application number
CZ1997209A
Other languages
Czech (cs)
English (en)
Other versions
CZ20997A3 (en
Inventor
Alison Mary Badger
Peter John Bugelski
Danuta J Herzyk
Original Assignee
Anormed Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Anormed Inc filed Critical Anormed Inc
Publication of CZ20997A3 publication Critical patent/CZ20997A3/cs
Publication of CZ286482B6 publication Critical patent/CZ286482B6/cs

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/438—The ring being spiro-condensed with carbocyclic or heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
CZ1997209A 1994-07-23 1995-07-14 Medicament for treating casual infections in mammals including human beings CZ286482B6 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9414902A GB9414902D0 (en) 1994-07-23 1994-07-23 Methods
PCT/US1995/008915 WO1996003126A1 (fr) 1994-07-23 1995-07-14 Procede de traitement des infections opportunistes avec des azaspiranes

Publications (2)

Publication Number Publication Date
CZ20997A3 CZ20997A3 (en) 1997-10-15
CZ286482B6 true CZ286482B6 (en) 2000-04-12

Family

ID=10758802

Family Applications (1)

Application Number Title Priority Date Filing Date
CZ1997209A CZ286482B6 (en) 1994-07-23 1995-07-14 Medicament for treating casual infections in mammals including human beings

Country Status (15)

Country Link
EP (1) EP0804201A4 (fr)
JP (1) JPH10503202A (fr)
KR (1) KR970704446A (fr)
CN (1) CN1157564A (fr)
AU (1) AU684384B2 (fr)
BR (1) BR9508332A (fr)
CA (1) CA2195778A1 (fr)
CZ (1) CZ286482B6 (fr)
GB (1) GB9414902D0 (fr)
HU (1) HUT77379A (fr)
MX (1) MX9700626A (fr)
NO (1) NO310096B1 (fr)
NZ (1) NZ290974A (fr)
WO (1) WO1996003126A1 (fr)
ZA (1) ZA956098B (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9601909A (pt) * 1995-07-13 1999-10-13 Smithkline Beecham Corp N,n-dietil-8,8-dipropil-2-azaspiro(4,5)decano-2-propan amina dimaleato

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4963557A (en) * 1987-09-28 1990-10-16 Smithkline Beecham Corporation Immunomodulatory azaspiranes
ZA921120B (en) * 1991-02-19 1993-01-27 Smithkline Beecham Corp Cytokine inhibitors
PT100566B (pt) * 1991-06-07 1999-06-30 Smithkline Beecham Corp Azaspiranos imunomoduladores, composicoes farmaceuticas que os contem, sua preparacao e seu uso

Also Published As

Publication number Publication date
WO1996003126A1 (fr) 1996-02-08
BR9508332A (pt) 1997-11-04
CA2195778A1 (fr) 1996-02-08
NO970284D0 (no) 1997-01-22
AU3190995A (en) 1996-02-22
JPH10503202A (ja) 1998-03-24
CN1157564A (zh) 1997-08-20
NZ290974A (en) 1999-08-30
HU9700201D0 (en) 1997-04-28
MX9700626A (es) 1997-05-31
GB9414902D0 (en) 1994-09-14
ZA956098B (en) 1996-05-23
CZ20997A3 (en) 1997-10-15
KR970704446A (ko) 1997-09-06
EP0804201A1 (fr) 1997-11-05
EP0804201A4 (fr) 2000-04-26
AU684384B2 (en) 1997-12-11
NO970284L (no) 1997-03-19
NO310096B1 (no) 2001-05-21
HUT77379A (hu) 1998-04-28

Similar Documents

Publication Publication Date Title
RU2355399C2 (ru) Противоопухолевые композиции, содержащие производное рапамицина и ингибитор ароматазы
JPH0555484B2 (fr)
NO334612B1 (no) Stabilisering av makrolider
JPH05262651A (ja) 向精神薬の安定化溶液
CZ284423B6 (cs) Použití lamotriginu pro přípravu léčiv určených k léčení neuronální degenerace způsobené AIDS
CZ284363B6 (cs) Použití protikřečových činidel k přípravě léčiv určených k léčení Parkinsonovy choroby a Parkinsonových syndromů
EP0542860B1 (fr) Compositions immunosuppressives
NZ509859A (en) Use of camptothecin derivatives, with reduced gastrointestinal toxicity
CZ286482B6 (en) Medicament for treating casual infections in mammals including human beings
US5786376A (en) Methods of treating opportunistic infections with azaspiranes
CA2946151C (fr) Composition solide stable d'immunosuppresseurs
US20100273733A1 (en) HIV Treatment
KR20060134232A (ko) 항궤양제 및 점막보호제를 함유하는 경구용 위장질환치료용 약제 조성물
US20220339175A1 (en) Application of Stachyose in Preparation of Drug for Treating Castration-Resistant Prostate Cancer
CZ281691B6 (cs) Farmaceutický prostředek proti vysokému krevnímu tlaku
EP0713391A1 (fr) Procede d'inhibition de la production de virus de l'immunodeficience chez l'homme au moyen d'azaspiranes substitues
JPH09500646A (ja) アザスピランによるｈｉｖの治療法
CA2128535A1 (fr) Methode de retardement du sida provoque par le vih par l'administration de composes azaperane substitues
AU710542B2 (en) Use of substituted azaspirane in the treatment of asthma
EP1713476A2 (fr) Formulation contenant du rabeprazole
US20040248926A1 (en) Preventive or remedy for pruritus
KR20230157119A (ko) B형 간염 예방 또는 치료용 약학 조성물
US20010014676A1 (en) Immunosuppressive compositions
JP2005520806A (ja) がん治療を改善する併用療法におけるキナゾリノン化合物
EP3463374A1 (fr) Composition pharmaceutique à action prolongée à base d'un inhibiteur de protéase

Legal Events

Date Code Title Description
IF00 In force as of 2000-06-30 in czech republic
MM4A Patent lapsed due to non-payment of fee

Effective date: 20020714